Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

HIV Infection

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 165 articles: HTML format

Single Articles

May 2023
1. THIPPABHOTLA S, Adeyemo B, Cooley SA, Roman J, et al
   Comparison of Resting State Functional Connectivity in Persons With and Without HIV: A Cross-sectional Study.
   J Infect Dis. 2023 May 25:jiad180. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. SCHWENKE JM, Thorball CW, Schoepf IC, Ryom L, et al
   Association of a Polygenic Risk Score with Osteoporosis in People Living with HIV: The Swiss HIV Cohort Study.
   J Infect Dis. 2023 May 24:jiad179. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. SABO MC, Lokken EM, Srinivasan S, Kinuthia J, et al
   Changes in vaginal bacteria and inflammatory mediators from periconception through early-postpartum in a cohort of HIV-negative Kenyan women.
   J Infect Dis. 2023 May 19:jiad168. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. HARTANA CA, Garcia Broncano P, Maswabi K, Ajibola G, et al
   Immune modulation of HIV-1 reservoir size in early-treated neonates.
   J Infect Dis. 2023 May 18:jiad173. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. DURSTENFELD MS, Peluso MJ, Kaveti P, Hill C, et al
   Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.
   J Infect Dis. 2023 May 11:jiad131. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. ROBINSON JA, Mahmud FJ, Greif E, Toribio M, et al
   Osteopontin is an integral mediator of cardiac interstitial fibrosis in models of HIV infection.
   J Infect Dis. 2023 May 10:jiad149. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. THIO CL, Taddese M, Saad Y, Zambo K, et al
   HBeAg-negative single hepatocyte analysis shows transcriptional silencing and slow decay of infected cells with treatment.
   J Infect Dis. 2023 May 2:jiad124. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2023
8. WHITTLES LK, Galiwango RM, Mpagazi J, Tobian AAR, et al
   Age patterns of HSV-2 incidence and prevalence in two Ugandan communities: a catalytic incidence model applied to population-based seroprevalence data.
   J Infect Dis. 2023 Apr 20:jiad113. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. ROBINSON JA, Niu M, Fox HS, Burdo TH, et al
   Antiretroviral therapy ameliorates SIV-associated myocarditis by dampening interferon signaling and pathogen response in the heart.
   J Infect Dis. 2023 Apr 19:jiad105. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. CLIFFORD GM, Wei F
    Prevention of Human Papillomavirus-Related Anal Cancer in Women Living With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:929-931.
    PubMed    
    
    
    
11. LIU Y, Weiss K, Zamudio AR, Hayes MP, et al
    Primary Anal Cancer Screening Results From 381 Women With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227:932-938.
    PubMed     Abstract available
    
    
    
12. ALEMNJI G, Mosha F, Maggiore P, Alexander H, et al
    Building Integrated Testing Programs for Infectious Diseases.
    J Infect Dis. 2023 Apr 12:jiad103. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. ROCCO JM, Laidlaw E, Galindo F, Anderson M, et al
    Mycobacterial Immune Reconstitution Inflammatory Syndrome in HIV is Associated With Protein-Altering Variants in Hemophagocytic Lymphohistiocytosis-Related Genes.
    J Infect Dis. 2023 Apr 11:jiad059. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. RAI MA, Shi V, Kennedy BD, Justement JS, et al
    Impact of mpox virus infection on immune parameters of a female person with HIV receiving clinically effective antiretroviral therapy.
    J Infect Dis. 2023 Apr 6:jiad096. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. SUTHAR AB, Ouk V, Samreth S, Ngauv B, et al
    Programmatic Implications of National Recent HIV Infection Surveillance in Cambodia.
    J Infect Dis. 2023 Apr 1:jiad082. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
16. SONG S, Satta S, Sharma MB, Hugo C, et al
    Mitoquinone Mesylate and Mitochondrial DNA in End Organs in Humanized Mouse Model of Chronic Treated Human Immunodeficiency Virus Infection.
    J Infect Dis. 2023 Mar 24:jiad044. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. SMITH CL, Bednarchik B, Aung H, Wilk DJ, et al
    Humoral and Cellular Immunity Induced by Adjuvanted and Standard Trivalent Influenza Vaccine in Older Nursing Home Residents.
    J Infect Dis. 2023 Mar 23:jiad071. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. JOSEPH SB, Gianella S, Burdo TH, Cinque P, et al
    Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.
    J Infect Dis. 2023;227.
    PubMed     Abstract available
    
    
    
19. AUNG HL, Alagaratnam J, Chan P, Chow FC, et al
    Cognitive Health in Persons With Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging.
    J Infect Dis. 2023;227.
    PubMed    
    
    
    
20. MUKERJI SS, Petersen KJ, Pohl KM, Dastgheyb RM, et al
    Machine Learning Approaches to Understand Cognitive Phenotypes in People With HIV.
    J Infect Dis. 2023;227.
    PubMed     Abstract available
    
    
    
21. O'CONNOR EE, Sullivan EV, Chang L, Hammoud DA, et al
    Imaging of Brain Structural and Functional Effects in People With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227.
    PubMed     Abstract available
    
    
    
22. MCINTOSH RC, Clark US, Cherner M, Cysique LA, et al
    The Evolution of Assessing Central Nervous System Complications in Human Immunodeficiency Virus: Where Do We Go From Here?
    J Infect Dis. 2023;227.
    PubMed     Abstract available
    
    
    
23. RAO VR, Brouwers P, Joseph J, Lawhorn C, et al
    Biotypes of Central Nervous System Complications in People Living With Human Immunodeficiency Virus (HIV): National Institute of Mental Health Perspectives on Advancing the Future of HIV Healthcare.
    J Infect Dis. 2023;227.
    PubMed     Abstract available
    
    
    
24. RUBIN LH, Ances BM
    Moving Toward Disentangling Heterogeneity in Central Nervous System Complications in People With Human Immunodeficiency Virus.
    J Infect Dis. 2023;227.
    PubMed    
    
    
    
25. ALKHATIB B, Jabari M, Bilasy S, Abdul-Rahman H, et al
    Resistance to HIV-1 Infection Conferred by a Compound CCR5Delta32 and CCR5 C20S Heterozygote.
    J Infect Dis. 2023 Mar 13:jiad062. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. HASTIE E, Moser C, Sun X, Lennox J, et al
    Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy.
    J Infect Dis. 2023 Mar 7:jiad060. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
27. LI Y, You S, Lee K, Yaesoubi R, et al
    The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018.
    J Infect Dis. 2023 Feb 18:jiad047. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. POVEDA E, Fitzgerald W, Reglero C, Perez-Gonzalez A, et al
    IL-18 and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1.
    J Infect Dis. 2023 Feb 15:jiad042. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. GANDHI RT, Bosch RJ, Mar H, Laird GM, et al
    Varied Patterns of Decay of Intact HIV-1 Proviruses Over two Decades of Art.
    J Infect Dis. 2023 Feb 10:jiad039. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. LI P, Li J, Ayada I, Avan A, et al
    Clinical features, antiviral treatment and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks.
    J Infect Dis. 2023 Feb 3:jiad034. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2023
31. CHAMBERS C, Deeks SL, Sutradhar R, Cox J, et al
    Vaccine effectiveness against 12-month incident and persistent anal human papillomavirus infection among gay, bisexual, and other men who have sex with men.
    J Infect Dis. 2023 Jan 19:jiad005. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. LI Y, Lefebvre F, Nakku-Joloba E, Ronald A, et al
    Upregulation of PTPRC and Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection.
    J Infect Dis. 2023 Jan 13:jiac498. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. SHIAU S, Jacobson DL, Huo Y, Kacanek D, et al
    Unique profile of inflammation and immune activation in pregnant people with HIV in the United States.
    J Infect Dis. 2023 Jan 2:jiac501. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. PHILLIPS S, Cornall AM, Molano M, Jin F, et al
    Performance of human papillomavirus (HPV) attribution algorithms to predict causative genotypes in anal high-grade lesions.
    J Infect Dis. 2023 Jan 2:jiac503. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2022
35. REILLY CS, Borges AH, Baker JV, Safo SE, et al
    Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons with HIV.
    J Infect Dis. 2022 Dec 29:jiac496. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. DONNELLAN S, Pennington SH, Ruggiero A, Martinez-Rodriguez C, et al
    A quantitative method for the study of HIV-1 and Mycobacterium tuberculosis co-infection.
    J Infect Dis. 2022 Dec 20:jiac491. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. TOVINH M, Horr G, Hoffmeister C, Dobrikova K, et al
    HIV-associated microbial translocation may affect cytokine production of CD56bright NK cells via stimulation of monocytes.
    J Infect Dis. 2022 Dec 15:jiac485. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. DI DIEGO GARCIA F, Cabrerizo G, Paletta A, Perez PS, et al
    Resistance to Prostaglandin E2 promotes monocyte activation during chronic HIV infection.
    J Infect Dis. 2022 Dec 9:jiac480. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. HYLE EP, Kasaie P, Schwamm E, Stewart C, et al
    A growing number of men who have sex with men aging with HIV (2021-2031): a comparison of two microsimulation models.
    J Infect Dis. 2022 Dec 7:jiac473. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. FOURMAN LT, Stanley TL, Ockene MW, McClure CM, et al
    Proteomic Analysis of Hepatic Fibrosis in HIV-Associated NAFLD Demonstrates Upregulation of Immune Response and Tissue Repair Pathways.
    J Infect Dis. 2022 Dec 3:jiac475. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2022
41. LABARILE M, Loosli T, Zeeb M, Kusejko K, et al
    Quantifying and predicting ongoing Human Immunodeficiency Virus Type 1 (HIV-1) transmission dynamics in Switzerland using a distance-based clustering approach.
    J Infect Dis. 2022 Nov 26:jiac457. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. HAMUSONDE K, Nicca D, Gunthard HF, Stockle M, et al
    Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 compared.
    J Infect Dis. 2022 Nov 21:jiac459. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. JONGKEES MJ, Geers D, Hensley KS, Huisman W, et al
    Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination.
    J Infect Dis. 2022 Nov 19:jiac451. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. HAKRE S, Lakhal-Naouar I, King DB, Burns JL, et al
    Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019.
    J Infect Dis. 2022;226:1743-1752.
    PubMed     Abstract available
    
    
    
45. STIEH DJ, Barouch DH, Comeaux C, Sarnecki M, et al
    Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study.
    J Infect Dis. 2022 Nov 9. pii: 6812747. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. PALUMBO PJ, Grant-McAuley W, Grabowski MK, Zhang Y, et al
    Multiple infection and HIV superinfection among persons who inject drugs in Indonesia and Ukraine.
    J Infect Dis. 2022 Nov 8. pii: 6811512. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2022
47. LI Z, Winer RL, Ba S, Sy MP, et al
    Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance among Women in Senegal, West Africa.
    J Infect Dis. 2022 Oct 31. pii: 6782258. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. STRAIN JF, Cooley SA, Tomov D, Boerwinkle A, et al
    Abnormal MRI signature in virologically stable HIV individuals.
    J Infect Dis. 2022 Oct 25. pii: 6770683. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. JAO J, Sun S, Bonner LB, Legbedze J, et al
    Lower insulin sensitivity in newborns with in utero HIV and antiretroviral exposure who are uninfected in Botswana.
    J Infect Dis. 2022 Oct 14. pii: 6761332. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. ESHLEMAN SH, Fogel JM, Halvas EK, Piwowar-Manning E, et al
    HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention.
    J Infect Dis. 2022 Oct 14. pii: 6761331. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. BENET S, Blanch-Lombarte O, Ainsua-Enrich E, Pedreno-Lopez N, et al
    Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PLWH with poor immune reconstitution.
    J Infect Dis. 2022 Oct 6. pii: 6749018. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2022
52. URIU K, Cardenas P, Munoz E, Barragan V, et al
    Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection.
    J Infect Dis. 2022;226:1200-1203.
    PubMed     Abstract available
    
    
    
53. SMITH MSR, Mohan H, Ajaykumar A, Hsieh AYY, et al
    Second-generation HIV integrase inhibitors induce differentiation dysregulation and exert toxic effects in human embryonic stem cell and mouse models.
    J Infect Dis. 2022 Sep 19. pii: 6704757. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. HALL SA, Burns GS, Mooney BJ, Millen R, et al
    Hepatitis B Virus Flares following Nucleot(s)ide Analogue Cessation Are Associated with Activation of TLR Signalling Pathways.
    J Infect Dis. 2022 Sep 15. pii: 6701634. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. PELUSO MJ, Mitchell A, Wang CY, Takahashi S, et al
    Low Prevalence of Interferon-alpha Autoantibodies in People Experiencing Long COVID Symptoms.
    J Infect Dis. 2022 Sep 12. pii: 6696027. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. MARGOT NA, Naik V, VanderVeen L, Anoshchenko O, et al
    Resistance analyses in Highly Treatment-Experienced People with HIV Treated with the Novel Capsid HIV Inhibitor Lenacapavir.
    J Infect Dis. 2022 Sep 9. pii: 6694734. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. MEHTA SD, Nandi D, Agingu W, Green SJ, et al
    Vaginal and Penile Microbiome Associations With Herpes Simplex Virus Type 2 in Women and Their Male Sex Partners.
    J Infect Dis. 2022;226:644-654.
    PubMed     Abstract available
    
    
    
58. GAYEDYU-DENNIS D, Fallah MP, Drew C, Badio M, et al
    Identifying pauci-/asymptomatic and unrecognized Ebola virus disease among close contacts based on exposure risk assessments and screening algorithms.
    J Infect Dis. 2022 Sep 1. pii: 6679723. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
59. VETTER BN, Reipold EI, Ongarello S, Audu R, et al
    Sensitivity and Specificity of Rapid Diagnostic Tests for Hepatitis C Virus With or Without HIV Coinfection: A Multicentre Laboratory Evaluation Study.
    J Infect Dis. 2022;226:420-430.
    PubMed     Abstract available
    
    
    
60. HWA SH, Snyman J, Bernstein M, Ganga Y, et al
    HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization.
    J Infect Dis. 2022 Aug 17. pii: 6670446. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. GARDNER AR, Ma Y, Bacchetti P, Price JC, et al
    Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
    J Infect Dis. 2022 Aug 11. pii: 6650396. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. SAMSUNDER N, de Vos M, Ngcapu S, Giandhari J, et al
    Clinical evaluation of SARS-CoV-2 rapid antigen tests during the Omicron wave in South Africa.
    J Infect Dis. 2022 Aug 3. pii: 6654839. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2022
63. VIVALDI G, Jolliffe DA, Faustini S, Shields AM, et al
    Correlation between post-vaccination anti-Spike antibody titres and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study.
    J Infect Dis. 2022 Jul 30. pii: 6652292. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. BABALOLA CM, Siebert JC, Kallapur SG, Maecker HT, et al
    Discrete Plasma Cytokine Profiles among Pregnant Women in Botswana by Chlamydia trachomatis infection, HIV status, and Gestational age.
    J Infect Dis. 2022 Jul 25. pii: 6649668. doi: 10.1093.
    PubMed    
    
    
    
65. TORIBIO M, Wilks MQ, Hedgire S, Lu MT, et al
    Increased Macrophage-Specific Arterial Infiltration Relates to Non-calcified Plaque and Systemic Immune Activation in People with HIV.
    J Infect Dis. 2022 Jul 20. pii: 6646962. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. MAHANT A, Guerguis S, Blevins TP, Cheshenko N, et al
    Herpes Simplex Virus Glycoprotein D Antibodies Fail to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines.
    J Infect Dis. 2022 Jul 14. pii: 6644507. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. ROGANDO AC, Weber KM, Xing J, Xue X, et al
    The IDOze Study: The Link between Sleep Disruption and Tryptophan-Kynurenine Pathway Activation in Women with HIV.
    J Infect Dis. 2022 Jul 8. pii: 6633821. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. COSSU MV, Mileto D, Giacomelli A, Oreni L, et al
    Does the co-morbidity burden contribute to suboptimal immunological responses to COVID-19 vaccination in people living with HIV?
    J Infect Dis. 2022 Jul 7. pii: 6633353. doi: 10.1093.
    PubMed    
    
    
    June 2022
69. HUNIDZARIRA P, Brown ER, Chirenje ZM, Hillier SL, et al
    Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials.
    J Infect Dis. 2022 Jun 28. pii: 6619245. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. LLIBRE JM, Revollo B, Aguilar S, Calomarde-Gomez C, et al
    Protection against severe clinical outcomes with adenovirus or mRNA SARS-CoV-2 vaccines in patients hospitalized with Covid-19.
    J Infect Dis. 2022 Jun 28. pii: 6619237. doi: 10.1093.
    PubMed    
    
    
    
71. HICKEY MD, Imbert E, Appa A, Del Rosario JB, et al
    HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness.
    J Infect Dis. 2022 Jun 27. pii: 6618638. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. MOODIE Z, Dintwe O, Sawant S, Grove D, et al
    Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.
    J Infect Dis. 2022 Jun 27. pii: 6618597. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. NYAWANDA BO, Otieno NA, Otieno MO, Emukule GO, et al
    The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya.
    J Infect Dis. 2022;225:2097-2105.
    PubMed     Abstract available
    
    
    
74. CUSTER B, Grebe E, Buccheri R, Bakkour S, et al
    Surveillance for Zika, chikungunya and dengue virus incidence and RNAemia in blood donors at four Brazilian blood centers during 2016-2019.
    J Infect Dis. 2022 Jun 11. pii: 6605709. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. QUINN MK, Williams PL, Muhihi A, Duggan CP, et al
    Timing of antiretroviral therapy initiation and birth outcomes among pregnant women living with HIV in Tanzania.
    J Infect Dis. 2022 Jun 9. pii: 6604810. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. JACOBSON JM
    Immune Responses to SARS-CoV-2 Vaccination in People With HIV: A Tale of Two Pandemics.
    J Infect Dis. 2022 Jun 7. pii: 6603522. doi: 10.1093.
    PubMed    
    
    
    
77. LAPOINTE HR, Mwimanzi F, Cheung PK, Sang Y, et al
    People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses.
    J Infect Dis. 2022 Jun 7. pii: 6603521. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. TAYLOR SA, Sharma S, Remmel CAL, Holder B, et al
    HIV-associated alterations of the biophysical features of maternal antibodies correlate with their reduced transfer across the placenta.
    J Infect Dis. 2022 Jun 6. pii: 6603519. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
79. MWIMANZI F, Lapointe HR, Cheung PK, Sang Y, et al
    Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose.
    J Infect Dis. 2022 May 11. pii: 6583561. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. KOLOSSVARY M, deFilippi C, Lu MT, Zanni MV, et al
    Proteomic Signature of Subclinical Coronary Artery Disease in People with HIV: Analysis of the REPRIEVE Mechanistic Substudy.
    J Infect Dis. 2022 May 10. pii: 6583088. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. EL SAHLY HM, Baden LR, Essink B, Montefiori D, et al
    Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 COVE Trial.
    J Infect Dis. 2022 May 10. pii: 6583011. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. CINDI Z, Kawuma AN, Maartens G, Bradford Y, et al
    Pharmacogenetics of dolutegravir plasma exposure among Southern Africans living with HIV.
    J Infect Dis. 2022 May 4. pii: 6580078. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. MOHAREB AM, Liu AF, Kim AY, Coffie PA, et al
    Clearance of hepatitis B "e" antigen in untreated chronic HBV infection: a systematic review and meta-analysis.
    J Infect Dis. 2022 May 2. pii: 6576758. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. GIBBS A, Healy K, Kaldhusdal V, Sundling C, et al
    MAIT cells are preserved in the cervical mucosa of HIV-infected women and exhibit a dominant expression of the TRAV1-2-TRAJ20 TCRalpha chain.
    J Infect Dis. 2022 May 2. pii: 6576501. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. JACOBS JL, Naqvi A, Shah FA, Boltz VF, et al
    Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19.
    J Infect Dis. 2022 May 2. pii: 6576503. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. WALKER NF, Karim F, Moosa M, Moodley S, et al
    Elevated Plasma Matrix Metalloproteinase-8 associates with Sputum Culture Positivity in Pulmonary Tuberculosis.
    J Infect Dis. 2022 May 1. pii: 6576469. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2022
87. CHAUDRON SE, Leemann C, Kusejko K, Nguyen H, et al
    A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV Cohort Study.
    J Infect Dis. 2022 Apr 29. pii: 6575836. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. PETERSEN KJ, Strain J, Cooley S, Vaida F, et al
    Machine learning quantifies accelerated white-matter aging in persons with HIV.
    J Infect Dis. 2022 Apr 28. pii: 6575226. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. SPATOLA M, Loos C, Cizmeci D, Webb N, et al
    Functional compartmentalization of antibodies in the central nervous system during chronic HIV infection.
    J Infect Dis. 2022 Apr 13. pii: 6568136. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. MUGO C, Nduati R, Osoro E, Nyawanda BO, et al
    Comparable pregnancy outcomes for HIV-uninfected and HIV-infected women on antiretroviral treatment in Kenya.
    J Infect Dis. 2022 Apr 11. pii: 6566248. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. AFRAN L, Jambo KC, Nedi W, Miles DJC, et al
    Defective monocyte enzymatic function and an inhibitory immune phenotype in HIV-exposed uninfected African infants in the era of antiretroviral therapy.
    J Infect Dis. 2022 Apr 11. pii: 6566242. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. LOUVANTO K, Baral P, Burchell A, Ramanakumar A, et al
    Role of Human Leukocyte Antigen Allele Sharing in Human Papillomavirus Infection Transmission Among Heterosexual Couples: Findings From the Hitch Cohort Study.
    J Infect Dis. 2022 Apr 1. pii: 6562380. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. EDFELDT G, Lajoie J, Rohl M, Oyugi J, et al
    Regular Use of Depot Medroxyprogesterone Acetate Causes Thinning of the Superficial Lining and Apical Distribution of Human Immunodeficiency Virus Target Cells in the Human Ectocervix.
    J Infect Dis. 2022;225:1151-1161.
    PubMed     Abstract available
    
    
    March 2022
94. REEVES RM, van Wijhe M, Lehtonen T, Stona L, et al
    A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis.
    J Infect Dis. 2022 Mar 25. pii: 6554001. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. WEI F, Xia N, Ocampo R, Goodman MT, et al
    Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies.
    J Infect Dis. 2022 Mar 23. pii: 6553063. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. TOVINH M, Horr G, Dobrikova K, Gotter C, et al
    Mitochondrial dysfunction contributes to impaired cytokine production of CD56 bright NK cells from HIV(+) individuals under effective antiviral therapy.
    J Infect Dis. 2022 Mar 21. pii: 6551690. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. ESHLEMAN SH, Fogel JM, Piwowar-Manning E, Chau G, et al
    Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084.
    J Infect Dis. 2022 Mar 18. pii: 6549543. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. RINDLER AE, Kusejko K, Kuster H, Neumann K, et al
    The interplay between replication capacity of HIV-1 and surrogate markers of disease.
    J Infect Dis. 2022 Mar 17. pii: 6550309. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. POVEDA E, Tabernilla A, Fitzgerald W, Salgado-Barreira A, et al
    Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control.
    J Infect Dis. 2022;225:1040-1049.
    PubMed     Abstract available
    
    
    
100. KROON E, Chottanapund S, Buranapraditkun S, Sacdalan C, et al
     Paradoxically greater persistence of HIV RNA+ cells in lymphoid tissue when ART is initiated in the earliest stage of infection.
     J Infect Dis. 2022 Mar 11. pii: 6547240. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. TANKO RF, Bunjun R, Dabee S, Jaumdally SZ, et al
     The Effect Of Contraception On Genital Cytokines In Women Randomized To Copper Intrauterine Device, Intramuscular Depot Medroxyprogesterone Acetate Or Levonorgestrel Implant.
     J Infect Dis. 2022 Mar 9. pii: 6545868. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. HALL EW, Weng MK, Harris AM, Schillie S, et al
     Assessing the cost-utility of universal hepatitis B vaccination among adults.
     J Infect Dis. 2022 Mar 9. pii: 6545195. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. VAN KAMPEN JJA, Dalm VASH, Fraaij PLA, Oude Munnink BB, et al
     Clinical and in-vitro evidence favoring immunoglobulin treatment of a chronic norovirus infection in a patient with common variable immunodeficiency.
     J Infect Dis. 2022 Mar 7. pii: 6543890. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2022
104. BOTTANELLI M, Ceccarelli D, Galli L, Castagna A, et al
     Response to Cyktor Et Al.
     J Infect Dis. 2022 Feb 26. pii: 6537607. doi: 10.1093.
     PubMed    
     
     
     
105. TEPEKULE B, Kusejko K, Zeeb M, Tarr PE, et al
     Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study.
     J Infect Dis. 2022 Feb 16. pii: 6529706. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. PAVLINAC P, Singa B, Huang ML, Shrestha L, et al
     Cytomegalovirus viremia predicts post-discharge mortality in Kenyan HIV-exposed uninfected children.
     J Infect Dis. 2022 Feb 13. pii: 6527814. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. BOSCH RJ, Gandhi RT, Mar H, Eron JJ, et al
     Associations between multiple measures of HIV-1 persistence on suppressive antiretroviral therapy.
     J Infect Dis. 2022 Feb 4. pii: 6522965. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. MAHOMED S, Garrett N, Capparelli EV, Osman F, et al
     Safety and pharmacokinetics of monoclonal antibodies VRC07-523LS and PGT121 administered subcutaneously for HIV prevention.
     J Infect Dis. 2022 Feb 4. pii: 6522857. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. SMITH RA, Wu VH, Song J, Raugi DN, et al
     Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations In HIV-2 Integrase: A Phenotypic Analysis Using An Expanded Panel of Site-Directed Mutants.
     J Infect Dis. 2022 Feb 3. pii: 6521074. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. LAU JSY, Cromer D, Pinkevych M, Lewin SR, et al
     Balancing statistical power and risk in HIV cure clinical trial design.
     J Infect Dis. 2022 Feb 1. pii: 6519358. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2022
111. LAURIE C, El-Zein M, Tota J, Khosrow-Khavar F, et al
     Efficacy of a carrageenan gel in increasing clearance of anal HPV infections in men: interim analysis of a double-blind randomized controlled trial.
     J Infect Dis. 2022 Jan 28. pii: 6516990. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. GELPI M, Vestad B, Raju SC, Hansen SH, et al
     Association of the kynurenine pathway of tryptophan metabolism with HIV-related gut microbiota alterations and visceral adipose tissue accumulation.
     J Infect Dis. 2022 Jan 28. pii: 6516797. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. ZURCHER K, Riou J, Morrow C, Ballif M, et al
     Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.
     J Infect Dis. 2022 Jan 18. pii: 6510424. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. ZHANG Y, D'Souza G, Fakhry C, Bigelow EO, et al
     Oral HPV associated with differences in oral microbiota beta diversity and microbiota abundance.
     J Infect Dis. 2022 Jan 17. pii: 6509880. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. KHALFI P, Suspene R, Caval V, Thiers V, et al
     APOBEC3C S188I polymorphism enhances context specific editing of Hepatitis B virus genome.
     J Infect Dis. 2022 Jan 12. pii: 6504007. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. L'HONNEUR AS, Pipoli Da Fonseca J, Cokelaer T, Rozenberg F, et al
     JC Polyomavirus whole genome sequencing at the single molecule level reveals emerging neurotropic populations in Progressive Multifocal Leucoencephalopathy.
     J Infect Dis. 2022 Jan 3. pii: 6494525. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2021
117. LUCIER A, Fong Y, Li SH, Dennis M, et al
     Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV.
     J Infect Dis. 2021 Dec 28. pii: 6486389. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. WEITZMANN MN, Weiss D, Vikulina T, Roser-Page S, et al
     Immune Reconstitution Bone Loss Exacerbates Bone Degeneration Due to Natural Aging in a Mouse Model.
     J Infect Dis. 2021 Dec 28. pii: 6485936. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. VERBURGH ML, Boyd A, Wit FWNM, Schim van der Loeff MF, et al
     Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV.
     J Infect Dis. 2021 Dec 20. pii: 6470931. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. SAHA A, Escudero J, Layouni T, Richardson B, et al
     Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum.
     J Infect Dis. 2021 Dec 20. pii: 6470923. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. VILLALBA JA, Maus MV, Frigault MJ, Zaffini R, et al
     False-positive HIV testing in patients receiving lentivirus-based chimeric antigen receptor T-cell therapy: A case report, review of the literature and proposed recommendations.
     J Infect Dis. 2021 Dec 20. pii: 6470480. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. SCHOEPF IC, Thorball CW, Ledergerber B, Kootstra NA, et al
     Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years.
     J Infect Dis. 2021 Dec 15. pii: 6463311. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. POERIO N, Caccamo N, La Manna MP, Olimpieri T, et al
     Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages.
     J Infect Dis. 2021 Dec 15. pii: 6463308. doi: 10.1093.
     PubMed     Abstract available
     
     
     
124. BROCKMAN MA, Mwimanzi F, Lapointe HR, Sang Y, et al
     Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults.
     J Infect Dis. 2021 Dec 9. pii: 6458430. doi: 10.1093.
     PubMed     Abstract available
     
     
     
125. MASWIME S, Pule C, Mtshali Z, Chawana R, et al
     HIV, Placental Lesions, and Adverse Perinatal Outcomes.
     J Infect Dis. 2021;224.
     PubMed     Abstract available
     
     
     
126. AUSTIN MN, Meyn LA, Avolia HA, Petrina MA, et al
     Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.
     J Infect Dis. 2021 Dec 4. pii: 6449486. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. KATSUYA H, Cook LBM, Rowan AG, Melamed A, et al
     Erratum to: Clonality of HIV-1- and HTLV-1-Infected Cells in Naturally Coinfected Individuals.
     J Infect Dis. 2021 Dec 4. pii: 6449345. doi: 10.1093.
     PubMed    
     
     
     November 2021
128. BARES SH, Smeaton LM, Scott SE, Smith BA, et al
     The Association Between Weight Gain, Sex, and Immune Activation Following the Initiation of Antiretroviral Therapy.
     J Infect Dis. 2021;224:1765-1774.
     PubMed     Abstract available
     
     
     
129. TAILOR J, Foldi J, Generoso M, McCarty B, et al
     Disease Progression in Children With Perinatal Human Immunodeficiency Virus Correlates With Increased PD-1+ CD8 T Cells That Coexpress Multiple Immune Checkpoints.
     J Infect Dis. 2021;224:1785-1795.
     PubMed     Abstract available
     
     
     
130. RAFFENBERG M, Engel T, Schoepf IC, Kootstra NA, et al
     Impact of Delaying Antiretroviral Treatment During Primary Human Immunodeficiency Virus Infection on Telomere Length.
     J Infect Dis. 2021;224:1775-1784.
     PubMed     Abstract available
     
     
     
131. FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
     COVID-19 Vaccination Rates in a Global HIV Cohort.
     J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
     PubMed     Abstract available
     
     
     
132. BALAKRISHNA S, Wolfensberger A, Kachalov V, Roth JA, et al
     Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study.
     J Infect Dis. 2021 Nov 18. pii: 6430793. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. DUARTE G, Muresan P, Ward S, Laimon L, et al
     Immunogenicity of conjugated and polysaccharide pneumococcal vaccines administered during pregnancy or postpartum to women with HIV.
     J Infect Dis. 2021 Nov 16. pii: 6429421. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. STOCKDALE AJ, Meiring JE, Shawa IT, Thindwa D, et al
     Hepatitis B vaccination impact and the unmet need for antiviral treatment in Blantyre, Malawi.
     J Infect Dis. 2021 Nov 9. pii: 6424415. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2021
135. STERN J, Solomon A, Dantanarayana A, Pascoe R, et al
     Cell-associated HIV RNA has a Circadian Cycle in Males Living with HIV on Antiretroviral Therapy.
     J Infect Dis. 2021 Oct 16. pii: 6398479. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
     The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
     J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. SMITH JA, Garnett GP, Hallett TB
     The Potential Impact of Long-Acting Cabotegravir for HIV Prevention in South Africa: A Mathematical Modeling Study.
     J Infect Dis. 2021;224:1179-1186.
     PubMed     Abstract available
     
     
     
138. ROTH JA, Radevski G, Marzolini C, Rauch A, et al
     Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.
     J Infect Dis. 2021;224:1198-1208.
     PubMed     Abstract available
     
     
     
139. STONE M, Rosenbloom DIS, Bacchetti P, Deng X, et al
     Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
     J Infect Dis. 2021;224:1209-1218.
     PubMed     Abstract available
     
     
     
140. VERBOEKET SO, Wit FW, Verheij E, van Zoest RA, et al
     Human Immunodeficiency Virus (HIV)-Negative Men Who Have Sex With Men Have Higher CD8+ T-Cell Counts and Lower CD4+/CD8+ T-Cell Ratios Compared With HIV-Negative Heterosexual Men.
     J Infect Dis. 2021;224:1187-1197.
     PubMed     Abstract available
     
     
     
141. TINGGAARD M, Slotved HC, Fuursted K, Storgaard M, et al
     Oral and anal carriage of Streptococcus pneumoniae among sexually active men with HIV who have sex with men.
     J Infect Dis. 2021 Oct 8. pii: 6383604. doi: 10.1093.
     PubMed     Abstract available
     
     
     
142. AKATA K, Leung JM, Yamasaki K, Filho FSL, et al
     Altered polarization and impaired phagocytic activity of lung macrophages in people with HIV and COPD.
     J Infect Dis. 2021 Oct 5. pii: 6381638. doi: 10.1093.
     PubMed     Abstract available
     
     
     
143. LECUYER R, Issa N, Tessoulin B, Lavergne RA, et al
     Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia.
     J Infect Dis. 2021 Oct 4. pii: 6380657. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2021
144. PELUSO MJ, Lu S, Tang AF, Durstenfeld MS, et al
     Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
     J Infect Dis. 2021 Sep 27. pii: 6376537. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. GAY CL, James KS, Tuyishime M, Falcinelli SD, et al
     Stable Latent HIV Infection and Low-Level Viremia Despite Treatment with the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat.
     J Infect Dis. 2021 Sep 25. pii: 6375363. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2021
146. SCHNITTMAN SR, Deitchman AN, Beck-Engeser G, Ahn H, et al
     Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus.
     J Infect Dis. 2021;223:1621-1630.
     PubMed     Abstract available
     
     
     
147. MUKERJI SS, Misra V, Lorenz DR, Chettimada S, et al
     Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy.
     J Infect Dis. 2021;223:1601-1611.
     PubMed     Abstract available
     
     
     April 2021
148. ERLANDSON KM, Wilson MP, MaWhinney S, Rapaport E, et al
     The Impact of Moderate or High-Intensity Combined Exercise on Systemic Inflammation Among Older Persons With and Without HIV.
     J Infect Dis. 2021;223:1161-1170.
     PubMed     Abstract available
     
     
     
149. VINHAES CL, Sheikh V, Oliveira-de-Souza D, Wang J, et al
     An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study.
     J Infect Dis. 2021;223:1275-1283.
     PubMed     Abstract available
     
     
     March 2021
150. MAFFEI VJ, Siggins RW, Luo M, Brashear MM, et al
     Alcohol Use Is Associated With Intestinal Dysbiosis and Dysfunctional CD8+ T-Cell Phenotypes in Persons With Human Immunodeficiency Virus.
     J Infect Dis. 2021;223:1029-1039.
     PubMed     Abstract available
     
     
     
151. CHAZOT R, Botelho-Nevers E, Mariat C, Fresard A, et al
     Cystatin C and Urine Albumin to Creatinine Ratio Predict 5-Year Mortality and Cardiovascular Events in People Living With HIV.
     J Infect Dis. 2021;223:885-892.
     PubMed     Abstract available
     
     
     
152. ZHOU S, Sizemore S, Moeser M, Zimmerman S, et al
     Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.
     J Infect Dis. 2021;223:876-884.
     PubMed     Abstract available
     
     
     
153. RICH SN, Poschman K, Hu H, Mavian C, et al
     Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis.
     J Infect Dis. 2021;223:866-875.
     PubMed     Abstract available
     
     
     February 2021
154. RYOM L, Lundgren JD, Reiss P, Ross M, et al
     The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.
     J Infect Dis. 2021;223:632-637.
     PubMed     Abstract available
     
     
     
155. AJAYKUMAR A, Zhu M, Kakkar F, Brophy J, et al
     Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
     J Infect Dis. 2021;223:621-631.
     PubMed     Abstract available
     
     
     
156. POPOVICH KJ
     Using Genomic Sequencing to Delineate Community Networks of Methicillin-Resistant Staphylococcus aureus Transmission Among Men Who Have Sex With Men.
     J Infect Dis. 2021;223:543-546.
     PubMed    
     
     
     
157. FRANCESCHINI E, De Biasi S, Digaetano M, Bianchini E, et al
     Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy.
     J Infect Dis. 2021;223:482-493.
     PubMed     Abstract available
     
     
     
158. MAHOMED S, Garrett N, Baxter C, Abdool Karim Q, et al
     Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review.
     J Infect Dis. 2021;223:370-380.
     PubMed     Abstract available
     
     
     
159. CYKTOR JC, Bosch RJ, Mar H, Macatangay BJ, et al
     Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy.
     J Infect Dis. 2021;223:462-470.
     PubMed     Abstract available
     
     
     
160. SERRANO-VILLAR S, Sanchez-Carrillo S, Talavera-Rodriguez A, Lelouvier B, et al
     Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery.
     J Infect Dis. 2021;223:471-481.
     PubMed     Abstract available
     
     
     August 2020
161. TESSEMA SK, Hathaway NJ, Teyssier NB, Murphy M, et al
     Sensitive, highly multiplexed sequencing of microhaplotypes from the Plasmodium falciparum heterozygome.
     J Infect Dis. 2020 Aug 25. pii: 5897005. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2020
162. CATLETT B, Bajis S, Starr M, Dore GJ, et al
     Evaluation of the Aptima HCV Quant Dx Assay for HCV RNA detection from finger-stick capillary dried blood spot and venepuncture-collected samples.
     J Infect Dis. 2020 Jul 25. pii: 5876378. doi: 10.1093.
     PubMed     Abstract available
     
     
     
163. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
     Extent of in-utero transfer of tenofovir from mother to fetus: a paired analysis of hair specimens collected at birth from a cohort in the United States.
     J Infect Dis. 2020 Jul 4. pii: 5867166. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2019
164. PHILLIPS A, Cambiano V, Johnson L, Nakagawa F, et al
     Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance.
     J Infect Dis. 2019 Dec 18. pii: 5680588. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. WIJERS JNAP, Dukers-Muijrers NHTM, van Liere GAFS, Dirks JAMC, et al
     Men and women have an equal oropharyngeal and anorectal Chlamydia trachomatis bacterial load: a comparison of three anatomic sites.
     J Infect Dis. 2019 Dec 16. pii: 5678512. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: